z-logo
open-access-imgOpen Access
Cardiac surgery in patients with heparin induced thombocytopenia (HIT II)
Author(s) -
Miomir Jović,
Duško Nežić,
Branko Čalija,
Denis Nenadić,
Aleksandar Knežević,
Milorad Borzanović,
Borislav Krivokapić,
Ivana Petrović,
Bosko Djukanovic
Publication year - 2009
Publication title -
acta chirurgica iugoslavica
Language(s) - English
Resource type - Journals
eISSN - 2406-0887
pISSN - 0354-950X
DOI - 10.2298/aci0901047j
Subject(s) - medicine , cardiopulmonary bypass , heparin , cardiac surgery , anesthesia , mitral valve replacement , surgery , bolus (digestion) , thrombosis , complication , mitral valve , valve replacement , anticoagulant , argatroban , cardiology , thrombin , platelet , stenosis
Heparin-induced thrombocytopenia (HIT) might be life-threatening in patients undergoing open heart surgery, due to thromboembolic events, thrombocytopenia and bleeding. If cardiac surgery with cardiopulmonary bypass (CPB) is necessary, anticoagulation therapy will be based on usage of danaparoid or direct thrombin inhibitors. Female patient was switched from per oral anticoagulant therapy to low molecular heparin therapy preparing for reredo mitral valve replacement due to endocarditis and artificial valve thrombosis. In next 10 days, thrombocytopenia was obvious (Tr 302,000 mm3 to 11,000 mm3) , and diagnoses of HIT were done. Anticoagulant therapy was continued with danaparoid, 750 IU/12 h sc. During the surgery, reredo mitral valve replacement and aortocoronary bypass on anterior descending coronary artery, blood salvage technique with rhirudin (intravenous bolus 0.4 mg/kg, in CPB prajming solution 0.4 mg/kg and continuous infusion during CPB 0.15 mg/kg/h) during cardiopulmonary bypass was used. Active coagulation time and +++ were monitored, without any sign of micro thrombosis in circuit. Postoperatively, per oral anticoagulation therapy was initiated with prolonged postoperative treatment due to basic disease, endocarditis. Patient was discharged from hospital on 21st postoperative day without any complication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here